COMMUNIQUÉS West-GlobeNewswire

MindBio Launches Intox AI™ in Major Advancement for Drug Use Detection
04/06/2026
Technology powered by AI can Detect Cocaine, Cannabis, Psychedelics, Narcotic, Alcohol Use and Human Fatigue in Real-Time from Your Voice 15 World firsts claimed by the Company in patent applications filed Discoveries [...]
Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
04/06/2026
Leadership appointments fortify Genovyn’s scientific, translational, and development capabilities across its AI-driven platform WILMINGTON, N.C., June 04, 2026 (GLOBE NEWSWIRE) -- GENOVYN, an AI-enabled biotechnology [...]
NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances
04/06/2026
The landmark achievement reflects the collective impact of patients, donors, caregivers, researchers, volunteers, advocates, financial supporters and transplant partners advancing access to life-saving cell therapy [...]
Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award
04/06/2026
Applied Behavior Analysis International Brain Injury Special Interest Group Honors Four-Decade Career in Neurorehabilitation at 52nd Annual Conference BAKERSFIELD, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Centre for [...]
Sienna Senior Living Inc. Announces Voting Results From Annual Meeting
04/06/2026
MARKHAM, Ontario, June 04, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
04/06/2026
The full preclinical pharmacology package includes results from many solid tumors models including mesothelioma, bladder, triple negative breast cancer (TNBC) and neuroblastoma and the demonstration of the mechanism of [...]
The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
04/06/2026
EAGLE, Idaho, June 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care, and senior living companies, and Hartford [...]
Adam Ferrari Health Science Scholarship Application Deadline Approaches for 2026 Cycle
04/06/2026
Students Pursuing Careers in Health Science Have Until June 30, 2026, to Apply for the $20,000 Scholarship IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- The 2026 Adam Ferrari Health Science Scholarship is accepting [...]
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
04/06/2026
Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain neurostimulation Patent [...]
Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment
04/06/2026
The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery Elfrida, ARIZONA, June 04, 2026 (GLOBE NEWSWIRE [...]
DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS
04/06/2026
CROSSJECT Société anonyme au capital social de 5 977 067,50 Euros Siège social : 6, rue Pauline Kergomard, ZAC Parc Mazen Sully, 21000 Dijon 438 822 215 R.C.S. Dijon DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS [...]
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
04/06/2026
HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant [...]
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
04/06/2026
First Product Revenue Expected This Month, Opening New Commercial Chapter for Women's Health Innovator Limited-Time Launch Offer: 30% Off + Free Shipping SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc [...]
Noom Members Kept Losing Weight a Full Year After the Program Ended, Largest-Ever Noom Randomized Clinical Trial Shows
04/06/2026
Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued losing weight for the next 52 weeks — reaching an average 4.1% body weight loss by week 68. [...]
AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
04/06/2026
Video segment examines current Ebola outbreak concerns, unmet need surrounding the Bundibugyo strain and Ampligen’s previously published antiviral research Discussion highlights Ampligen’s immune-modulating mechanism, [...]
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
04/06/2026
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources GAITHERSBURG, Md., June 04, 2026 (GLOBE NEWSWIRE) -- In [...]
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
04/06/2026
First-in-human Phase I study met its primary endpoint, demonstrating favourable safety and tolerability in healthy volunteers in the single ascending dose part of the study Phase I data demonstrate statistically [...]
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
04/06/2026
NEW HAVEN, Conn., June 04, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it has recently joined the [...]
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
04/06/2026
FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals Continued demonstration of [...]

Pages